METHOD OF DIAGNOSING BREAST CANCER, MONITORING TREATMENT OF BREAST CANCER, AND TREATING BREAST CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Aug 15, 2017
filing date -
Aug 15, 2016
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Described are methods of detecting circulating HOTAIR in breast cancer patients. The detection of circulating HOTAIR may aid in the treatment of triple-negative breast cancer (“TNBC”) or anti-estrogen resistant breast cancer. Circulating HOTAIR may be quantified before and after treatment to determine effectiveness of the treatment. Aspects are directed to diagnosing and treating TNBC and/or anti-estrogen resistant breast cancers in a subject by detecting circulating HOTAIR levels from a sample in the patient. The treatments may include administering agents that decrease the activity of EGFR and c-ABL, such as lapatinib and imatinib, respectively. Additional embodiments of the treatments include administration of a chimeric aptamer that targets both EGFR activity and HOTAIR expression.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully